CD19 expression in B cells regulates atopic dermatitis in a mouse model

American Journal of Pathology

Volumn 182, Issue 6, 2013, Pages 2214-2222

  Yanaba, Koichi ^a   Kamata, Masahiro ^a   Asano, Yoshihide ^a   Tada, Yayoi ^a   Sugaya, Makoto ^a   Kadono, Takafumi ^a   Tedder, Thomas F ^b   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE SEVERITY; EOSINOPHIL; IN VITRO STUDY; LYMPH NODE CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD19; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; LYMPH NODES; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; SPLEEN; TH17 CELLS; TH2 CELLS;

EID: 84878261250     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.02.042     Document Type: Article

References (44)

1. T. Bieber Atopic dermatitis N Engl J Med 358 2008 1483 1494
2. G. Ponyai, B. Hidvegi, I. Nemeth, A. Sas, E. Temesvari, and S. Karpati Contact and aeroallergens in adulthood atopic dermatitis J Eur Acad Dermatol Venereol 22 2008 1346 1355
3. T. Mori, K. Ishida, S. Mukumoto, Y. Yamada, G. Imokawa, K. Kabashima, M. Kobayashi, T. Bito, M. Nakamura, K. Ogasawara, and Y. Tokura Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis Br J Dermatol 162 2010 83 90
4. H. Ott, S. Stanzel, C. Ocklenburg, H.F. Merk, J.M. Baron, and S. Lehmann Total serum IgE as a parameter to differentiate between intrinsic and extrinsic atopic dermatitis in children Acta Derm Venereol 89 2009 257 261
5. Q. Hamid, M. Boguniewicz, and D.Y. Leung Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis J Clin Invest 94 1994 870 876
6. Q. Hamid, T. Naseer, E.M. Minshall, Y.L. Song, M. Boguniewicz, and D.Y. Leung In vivo expression of IL-12 and IL-13 in atopic dermatitis J Allergy Clin Immunol 98 1996 225 231
7. C.N. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S.P. Lee, D.R. Goudie, A. Sandilands, L.E. Campbell, F.J. Smith, G.M. O'Regan, R.M. Watson, J.E. Cecil, S.J. Bale, J.G. Compton, J.J. DiGiovanna, P. Fleckman, S. Lewis-Jones, G. Arseculeratne, A. Sergeant, C.S. Munro, B. El Houate, K. McElreavey, L.B. Halkjaer, H. Bisgaard, S. Mukhopadhyay, and W.H. McLean Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
8. M. Akiyama FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics Br J Dermatol 162 2010 472 477
9. K.C. Barnes An update on the genetics of atopic dermatitis: scratching the surface in 2009 J Allergy Clin Immunol 125 2010 16 31
10. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, A. Debenedetto, L. Schneider, L.A. Beck, K.C. Barnes, and D.Y. Leung Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 120 2007 150 155
11. J.M. Spergel, E. Mizoguchi, H. Oettgen, A.K. Bhan, and R.S. Geha Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis J Clin Invest 103 1999 1103 1111
12. J.M. Spergel, E. Mizoguchi, J.P. Brewer, T.R. Martin, A.K. Bhan, and R.S. Geha Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice J Clin Invest 101 1998 1614 1622
13. K. Yanaba, J.D. Bouaziz, T. Matsushita, C.M. Magro, E.W. St Clair, and T.F. Tedder B-lymphocyte contributions to human autoimmune disease Immunol Rev 223 2008 284 299
14. E.A. Kurt-Jones, D. Liano, K.A. HayGlass, B. Benacerraf, M.S. Sy, and A.K. Abbas The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice J Immunol 140 1988 3773 3778
15. D.P. Harris, L. Haynes, P.C. Sayles, D.K. Duso, S.M. Eaton, N.M. Lepak, L.L. Johnson, S.L. Swain, and F.E. Lund Reciprocal regulation of polarized cytokine production by effector B and T cells Nat Immunol 1 2000 475 482
16. P.J. Linton, B. Bautista, E. Biederman, E.S. Bradley, J. Harbertson, R.M. Kondrack, R.C. Padrick, and L.M. Bradley Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo J Exp Med 197 2003 875 883
17. J.D. Bouaziz, K. Yanaba, and T.F. Tedder Regulatory B cells as inhibitors of immune responses and inflammation Immunol Rev 224 2008 201 214
18. K. Yanaba, A. Yoshizaki, Y. Asano, T. Kadono, T.F. Tedder, and S. Sato IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model Am J Pathol 178 2011 735 743
19. + phenotype controls T cell-dependent inflammatory responses Immunity 28 2008 639 650
20. T. Tsubata Co-receptors on B lymphocytes Curr Opin Immunol 11 1999 249 255
21. T.F. Tedder, M. Inaoki, and S. Sato The CD19/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity Immunity 6 1997 107 118
22. S. Sato, D.A. Steeber, P.J. Jansen, and T.F. Tedder CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19 J Immunol 158 1997 4662 4669
23. S. Sato, N. Ono, D.A. Steeber, D.S. Pisetsky, and T.F. Tedder CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity J Immunol 157 1996 4371 4378
24. P. Stashenko, L.M. Nadler, R. Hardy, and S.F. Schlossman Characterization of a human B lymphocyte-specific antigen J Immunol 125 1980 1678 1685
25. J. Uchida, Y. Lee, M. Hasegawa, Y. Liang, A. Bradney, J.A. Oliver, K. Bowen, D.A. Steeber, K.M. Haas, J.C. Poe, and T.F. Tedder Mouse CD20 expression and function Int Immunol 16 2004 119 129
26. P. Ponte, and M.J. Lopes Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy J Am Acad Dermatol 63 2010 355 356
27. D. Simon, S. Hosli, G. Kostylina, N. Yawalkar, and H.U. Simon Anti-CD20 (rituximab) treatment improves atopic eczema J Allergy Clin Immunol 121 2008 122 128
28. P. Engel, L.-J. Zhou, D.C. Ord, S. Sato, B. Koller, and T.F. Tedder Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule Immunity 3 1995 39 50
29. + T cell activation in mice Proc Natl Acad Sci U S A 104 2007 20882 20887
30. K. Yanaba, Y. Hamaguchi, G.M. Venturi, D.A. Steeber, E.W. St. Clair, and T.F. Tedder B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity J Immunol 179 2007 1369 1380
31. + T cells to produce IL-4 J Immunol 158 1997 4171 4179
32. Q. Liu, Z. Liu, C.T. Rozo, H.A. Hamed, F. Alem, J.F. Urban Jr., and W.C. Gause The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response J Immunol 179 2007 3821 3830
33. + dendritic cells and lymphotoxin-expressing B cells Nat Immunol 13 2012 681 690
34. Y. Souwer, K. Szegedi, M.L. Kapsenberg, and E.C. de Jong IL-17 and IL-22 in atopic allergic disease Curr Opin Immunol 22 2010 821 826
35. C. Koga, K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura Possible pathogenic role of Th17 cells for atopic dermatitis J Invest Dermatol 128 2008 2625 2630
36. F.L. van de Veerdonk, B. Lauwerys, R.J. Marijnissen, K. Timmermans, F. Di Padova, M.I. Koenders, I. Gutierrez-Roelens, P. Durez, M.G. Netea, J.W. van der Meer, W.B. van den Berg, and L.A. Joosten The anti-CD20 antibody rituximab reduces the Th17 cell response Arthritis Rheum 63 2011 1507 1516
37. E. Guttman-Yassky, M.A. Lowes, J. Fuentes-Duculan, L.C. Zaba, I. Cardinale, K.E. Nograles, A. Khatcherian, I. Novitskaya, J.A. Carucci, R. Bergman, and J.G. Krueger Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis J Immunol 181 2008 7420 7427
38. E. Saito, M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi, Y. Kaburagi, T. Nagaoka, K. Takehara, T.F. Tedder, and S. Sato CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse J Clin Invest 109 2002 1453 1462
39. C.J. Del Nagro, R.V. Kolla, and R.C. Rickert A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis J Immunol 175 2005 5379 5389
40. K. Komura, K. Yanaba, M. Horikawa, F. Ogawa, M. Fujimoto, T.F. Tedder, and S. Sato CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model Arthritis Rheum 58 2008 3574 3584
41. T. Matsushita, M. Fujimoto, M. Hasegawa, K. Komura, K. Takehara, T.F. Tedder, and S. Sato Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response Am J Pathol 168 2006 812 821
42. T. Matsushita, K. Yanaba, J.D. Bouaziz, M. Fujimoto, and T.F. Tedder Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression J Clin Invest 118 2008 3420 3430
43. K.M. Haas, J.C. Poe, D.A. Steeber, and T.F. Tedder B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae Immunity 23 2005 7 18
44. reg cells by B1 and B2 B cells Eur J Immunol 37 2007 2400 2404